Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020;5(11):847-860.
doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14.

A materials-science perspective on tackling COVID-19

Affiliations
Review

A materials-science perspective on tackling COVID-19

Zhongmin Tang et al. Nat Rev Mater. 2020.

Abstract

The ongoing SARS-CoV-2 pandemic highlights the importance of materials science in providing tools and technologies for antiviral research and treatment development. In this Review, we discuss previous efforts in materials science in developing imaging systems and microfluidic devices for the in-depth and real-time investigation of viral structures and transmission, as well as material platforms for the detection of viruses and the delivery of antiviral drugs and vaccines. We highlight the contribution of materials science to the manufacturing of personal protective equipment and to the design of simple, accurate and low-cost virus-detection devices. We then investigate future possibilities of materials science in antiviral research and treatment development, examining the role of materials in antiviral-drug design, including the importance of synthetic material platforms for organoids and organs-on-a-chip, in drug delivery and vaccination, and for the production of medical equipment. Materials-science-based technologies not only contribute to the ongoing SARS-CoV-2 research efforts but can also provide platforms and tools for the understanding, protection, detection and treatment of future viral diseases.

Keywords: Diseases; Materials science; Nanoscience and technology; Virology.

PubMed Disclaimer

Conflict of interest statement

Competing interestsO.C.F. has financial interests in Selecta Biosciences, Tarveda Therapeutics and Seer. R.L. receives licensing fees (to patents on which he was an inventor) from, invested in, consults (or was on scientific advisory boards or boards of directors) for, lectured (and received a fee) or conducts sponsored research at MIT for which he was not paid for the following entities: 7th Sense, Abpro Labs, Abpro Korea, Acorda (formerly Civitas Therapeutics), Aleph Farms, Alivio Therapeutics, Alkermes, Allevi, Alnylam Pharmaceuticals, Apotex, Arcadia Biosciences, Arsenal Medical, Artificial Cells, Avalon GloboCare, BASF, BioInnovation Institute, Blackstone, Boston Children’s Hospital, Celero, Cellomics, Cellular Biomedical, Charles River, Clontech, Combined Therapeutics, Conference Forum, Cornell University, CRISPR Therapeutics AG, Crown Bioscience, Cygnal Therapeutics, Daros, Daré Bioscience, DeepBiome, Dewpoint Therapeutics, Dispendix/Cellink, Domain, Eagle, EdiGene Biotechnology, Editas Medicine, Eli Lily, Eisai, Entrega, Everlywell, Evox Therapeutics, Flagship Pioneering, Frequency Therapeutics, GeneMedicine, GenScript USA, GENUV, GlaxoSmithKline, Glycobia, Glympse Bio, GreenLight Biosciences, HCR, Hopewell Therapeutics, Horizon Discovery, Humacyte, IBEX Pharmaceuticals, ImmuneXcite, Indivior, Inovio, Institute of Immunology, Integrated DNA Technologies, InVivo Therapeutics, IxBio, J.R. Simplot, Jnana Therapeutics, Kala Pharmaceuticals, Kallyope, Kensa, Kodikaz Therapeutics, KSQ Therapeutics, Landsdowne Labs, LikeMinds, Luminopia, Luye, Lyndra Therapeutics, Lyra Therapeutics, McGovern Institute, Medikinetics, Merck, MGH Ragon Institute, Micelle, Moderna Therapeutics, Momenta, Monsanto, Muse Biotechnologies, Mylan, Nanobiosym, Nanobiotix, NewBridge Ventures, Noveome Biotherapeutics, Novo Nordisk, Particles for Humanity, Pfizer, Pioneer Hi-Bred International, Polaris Partners, Portal Instruments, Preceres, Pulmatrix, PureTech, ReLive, ReproCELL USA, Rubius Therapeutics, Secant Medical, Seer, Selecta Biosciences, Senses Biosciences, Senses, Setsuro Tech, Seventh Sense Biosystems, Shenzhen Rice Life Technology, Shire AG, Shiseido, Siglion, Sigma-Aldrich, SiO2, SKE S.R.L., Soil Culture Solutions, SQZ Biotechnologies, StemBioSys, Suono Bio, T2 Biosystems, Taconic Biosciences, TARA, Tarveda Therapeutics, Tesio Pharmaceuticals, Third Rock, Tiba Biotech, TISSIUM, TransGen, Translate Bio, TriLink BioTechnologies, Unilever, VasoRx, Verseau Therapeutics, Vivtex, Whitehead Institute, Wiki Foods, YZ Biosciences and Zenomics.

Figures

Fig. 1
Fig. 1. SARS-CoV-2 and materials science.
a | The structure, transmission routes and replication cycles of SARS-CoV-2. b | Materials science contributes to the development and optimization of protective equipment and provides technologies and tools for the analysis of SARS-CoV-2, for example, high-resolution imaging, for sequencing (PCR) and protein analysis (immunoassays), for viral detection, for vaccine and treatment development and delivery, as well as by contributing advanced materials for clinical instruments, for example, filters for extracorporeal membrane oxygenation (ECMO) machines. SNP, single nucleotide polymorphism.
Fig. 2
Fig. 2. Materials science in viral research and protection.
a | Single-virus tracking workflow using fluorescence microscopy. The representative image shows an influenza virus in Chinese hamster ovary cells (z-stacked time-lapse images, the colour code from pink/blue to yellow/white indicates the timescale from 0 s to 500 s). b | There are three possible imaging geometries in single-virus tracking, that is, epifluorescence geometry (Epi), confocal microscopy and total internal reflection fluorescence (TIRF) geometry. c | Nanopore sequencing using a nanosize pore and sensing regions in Mycobacterium smegmatis porin A (MspA) and α-haemolysin. d | A self-powered air filter can capture particulate matter and nanoparticles by surface adhesion. Arg, argon ion; BS, beam splitter; CCD, charge-coupled device; DM, dichroic mirror; F, filter; M, mirror; Nd:YAG, neodymium-doped yttrium aluminium garnet; S, shutters; SL, optical slits to control image size. Top image of panel a adapted with permission from ref., PNAS. Panels a and b reprinted from ref., Springer Nature Limited. Panel c reprinted from ref., Springer Nature Limited. Panel d reprinted from ref., CC BY 4.0.
Fig. 3
Fig. 3. Materials science in virus detection.
a | Multiplexed Zika virus/dengue virus (ZIKV/DENV) antigen microarray combining nanostructured plasmonic gold and near-infrared fluorescence molecules. Antibodies against ZIKV and DENV antigens in human serum are first captured by the microarray and then labelled with anti-human immunoglobulin G-infrared fluorescent dye 680 (IgG-IRDye680) and immunoglobulin A-infrared fluorescent dye 800 (IgA-IRDye800). Binding between IgG and IgA with antigens is evaluated by measuring the fluorescence intensities of the two dyes. b | Nanowire-based detection of single viruses. Binding of the virus to a specific antibody (Ab) leads to a change in conductance. c | An external electrical pulse and biosensors based on graphene quantum dots (GQDs) and gold-embedded polyaniline nanowires (AuNP-PAni) can be used for the detection of hepatitis E virus (HEV). The biosensor electrode, which is based on anti-HEV Ab-conjugated to nitrogen and sulfur codoped graphene quantum dots and gold-embedded polyaniline nanowires (Ab-N,S-GQDs@AuNP-PAni), can capture HEV. The HEV concentration is determined from the pulse-induced impedimetric response. d | A single-molecule whispering gallery mode biosensor platform using plasmonic gold nanorods can be used to detect single nucleic acid molecules. EDC, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride; GCE, glass carbon electrode; NHS, N-hydroxysuccinimide; N,S-GQDs, nitrogen and sulfur codoped graphene quantum dots; PBS, polarizing beam splitter; PD, photodetector; PDMS, polydimethylsiloxane. Panel a reprinted from ref., Springer Nature Limited. Panel b reprinted with permission from ref., PNAS. Panel c reprinted from ref., CC BY 4.0. Panel d reprinted from ref., Springer Nature Limited.
Fig. 4
Fig. 4. Materials science in the treatment and vaccination of viral diseases.
a | Gold nanoparticles (AuNPs) coated with long and flexible moieties of undecanesulfonic acid (MUS) show viricidal activity against heparan sulfate proteoglycan (HSPG)-binding viruses, owing to the generation of high forces (~190 pN), which irreversibly deform the virus; by contrast, 3-mercaptoethylsulfonate (MES)-coated AuNPs are not antiviral because of the short molecule length. b | Nasal delivery of inactivated H1N1 influenza virus and pulmonary surfactant guanosine monophosphate–adenosine monophosphate (PS-GAMP; an activator of stimulator of interferon genes (STING)) leads to the stimulation of dendritic cell (DC) maturation, antibody generation and, subsequently, to a CD8+ T cell and tissue-resident memory T (TRM) cell response, generating broad protection against seasonal influenza B virus (IBV), H3N2, H5N1 and H7N9 influenza viruses. c | Lipid nanoparticles can be used for the delivery of a Zika virus pre-membrane and envelope (ZIKV prM-E)-encoding mRNA vaccine against the Zika virus. Delivering a ZIKV prM-E fusion loop mutant-encoding mRNA diminishes the generation of cross-reactive antibodies that promote Dengue virus infection. d | During extracorporeal membrane oxygenation, venous blood is drained from the body, oxygenated by fresh gas (the blender modulates the ratio between air and oxygen) using a gas-exchange device and then returned to the body. AEC, alveolar epithelial cell. Panel a reprinted from ref., Springer Nature Limited. Panel b from ref., Herold, S. & Sander, L.-E. Toward a universal flu vaccine. Science 367, 852–853 (2020). Redrawn with permission from AAAS. Panel c reprinted with permission from ref., Elsevier. Panel d from ref., N. Engl. J. Med. Brodie, D. & Bacchetta, M. Extracorporeal membrane oxygenation for ARDS in adults. 365, 1905–1914. Copyright © (2011) Massachusetts Medical Society. Reprinted with permission from Massachusetts Medical Society.
Fig. 5
Fig. 5. Timeline of key contributions of materials science to virology.
FDA, US Food and Drug Administration; SHERLOCK, specific high-sensitivity enzymatic reporter unlocking.

Similar articles

Cited by

References

    1. Gates B. Responding to Covid-19 — a once-in-a-century pandemic? N. Engl. J. Med. 2020;382:1677–1679. - PubMed
    1. World Health Organization. Weekly operational update on COVID-19. 9 September 2020 (WHO, 2020).
    1. Johns Hopkins University. COVID-19 dashboard by the center for systems science and engineering (CSSE) at Johns Hopkins University (JHU). JHUhttps://coronavirus.jhu.edu/map.html (2020).
    1. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Vital surveillances: the epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) — China, 2020. China CDC Wkly2, 113–122 (2020). - PMC - PubMed
    1. Thorp HH. Time to pull together. Science. 2020;367:1282. - PubMed